Influenza virus antigens conjugated with a synthetic polyelectrolyte: a novel model of vaccines. 1985

R V Petrov, and R M Khaitov, and V M Zhdanov, and M S Sinyakov, and A Sh Norimov, and A V Nekrasov, and Podchernyaeva RYa, and I G Kharitonenkov, and M V Shchipanova

Haemagglutinin (HA), a mixture of haemagglutinin and neuraminidase (HA + NA), and matrix (M) protein were isolated from the influenza A virus and covalently coupled to a synthetic polyelectrolyte (P). A single injection into mice of the resultant conjugates (virogates) brought about efficient stimulation of the primary immune response specific to the corresponding viral antigens. Mice immunized with virogates HA.P or (HA + NA).P were largely protected against a lethal challenge infection with homologous virus. Immunization of mice with M.P virogate containing M protein originated from a 1934 influenza strain resulted in pronounced protection against a lethal challenge infection with a 1980 strain. Virogates are discussed as a novel model of artificial vaccines.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008808 Mice, Inbred CBA An inbred strain of mouse that is widely used in BIOMEDICAL RESEARCH. Mice, CBA,Mouse, CBA,Mouse, Inbred CBA,CBA Mice,CBA Mice, Inbred,CBA Mouse,CBA Mouse, Inbred,Inbred CBA Mice,Inbred CBA Mouse
D009439 Neuraminidase An enzyme that catalyzes the hydrolysis of alpha-2,3, alpha-2,6-, and alpha-2,8-glycosidic linkages (at a decreasing rate, respectively) of terminal sialic residues in oligosaccharides, glycoproteins, glycolipids, colominic acid, and synthetic substrate. (From Enzyme Nomenclature, 1992) Sialidase,Exo-alpha-Sialidase,N-Acylneuraminate Glycohydrolases,Oligosaccharide Sialidase,Exo alpha Sialidase,Glycohydrolases, N-Acylneuraminate,N Acylneuraminate Glycohydrolases,Sialidase, Oligosaccharide
D009980 Influenza A virus The type species of the genus ALPHAINFLUENZAVIRUS that causes influenza and other diseases in humans and animals. Antigenic variation occurs frequently between strains, allowing classification into subtypes and variants. Transmission is usually by aerosol (human and most non-aquatic hosts) or waterborne (ducks). Infected birds shed the virus in their saliva, nasal secretions, and feces. Alphainfluenzavirus influenzae,Avian Orthomyxovirus Type A,FLUAV,Fowl Plague Virus,Human Influenza A Virus,Influenza Virus Type A,Influenza Viruses Type A,Myxovirus influenzae-A hominis,Myxovirus influenzae-A suis,Myxovirus pestis galli,Orthomyxovirus Type A,Orthomyxovirus Type A, Avian,Orthomyxovirus Type A, Human,Orthomyxovirus Type A, Porcine,Pestis galli Myxovirus,Fowl Plague Viruses,Influenza A viruses,Myxovirus influenzae A hominis,Myxovirus influenzae A suis,Myxovirus, Pestis galli,Myxoviruses, Pestis galli,Pestis galli Myxoviruses,Plague Virus, Fowl,Virus, Fowl Plague
D010948 Viral Plaque Assay Method for measuring viral infectivity and multiplication in CULTURED CELLS. Clear lysed areas or plaques develop as the VIRAL PARTICLES are released from the infected cells during incubation. With some VIRUSES, the cells are killed by a cytopathic effect; with others, the infected cells are not killed but can be detected by their hemadsorptive ability. Sometimes the plaque cells contain VIRAL ANTIGENS which can be measured by IMMUNOFLUORESCENCE. Bacteriophage Plaque Assay,Assay, Bacteriophage Plaque,Assay, Viral Plaque,Assays, Bacteriophage Plaque,Assays, Viral Plaque,Bacteriophage Plaque Assays,Plaque Assay, Bacteriophage,Plaque Assay, Viral,Plaque Assays, Bacteriophage,Plaque Assays, Viral,Viral Plaque Assays
D011205 Povidone A polyvinyl polymer of variable molecular weight; used as suspending and dispersing agent and vehicle for pharmaceuticals; also used as blood volume expander. Polvidone,Polyvidon,Polyvinylpyrrolidone,Arufil,Bolinan,Bolinan 40,Crospovidone,Dulcilarmes,Duratears Free,Enterodes,Enterodez,Hypotears,Kollidon,Lacophtal,Lacri-Stulln,Lagrifilm,Liquifilm Lagrimas,Nutrivisc,Oculotect,PVP 40,Periston,Plasdone,Polyplasdone XL,Povidone, Unspecified,Protagens,Protagent,Unifluid,Vidirakt S mit PVP,Vidisic PVP Ophtiole,Wet-Comod,Dulcilarme,Enterode,Hypotear,Polyvidons,Protagen,Unspecified Povidone
D005260 Female Females
D005779 Immunodiffusion Technique involving the diffusion of antigen or antibody through a semisolid medium, usually agar or agarose gel, with the result being a precipitin reaction. Gel Diffusion Tests,Diffusion Test, Gel,Diffusion Tests, Gel,Gel Diffusion Test,Immunodiffusions,Test, Gel Diffusion,Tests, Gel Diffusion
D006389 Hemagglutinins, Viral Specific hemagglutinin subtypes encoded by VIRUSES. Viral Hemagglutinin,Viral Hemagglutinins,Hemagglutinin, Viral
D000180 Acrylic Resins Polymers of high molecular weight which are derived from acrylic acid, methacrylic acid or other related compounds and are capable of being molded and then hardened to form useful components. Acrylic Resin,Resin, Acrylic,Resins, Acrylic

Related Publications

R V Petrov, and R M Khaitov, and V M Zhdanov, and M S Sinyakov, and A Sh Norimov, and A V Nekrasov, and Podchernyaeva RYa, and I G Kharitonenkov, and M V Shchipanova
April 2009, Revue scientifique et technique (International Office of Epizootics),
R V Petrov, and R M Khaitov, and V M Zhdanov, and M S Sinyakov, and A Sh Norimov, and A V Nekrasov, and Podchernyaeva RYa, and I G Kharitonenkov, and M V Shchipanova
January 1989, Voprosy virusologii,
R V Petrov, and R M Khaitov, and V M Zhdanov, and M S Sinyakov, and A Sh Norimov, and A V Nekrasov, and Podchernyaeva RYa, and I G Kharitonenkov, and M V Shchipanova
August 1981, Immunology today,
R V Petrov, and R M Khaitov, and V M Zhdanov, and M S Sinyakov, and A Sh Norimov, and A V Nekrasov, and Podchernyaeva RYa, and I G Kharitonenkov, and M V Shchipanova
January 1983, Biopolymers,
R V Petrov, and R M Khaitov, and V M Zhdanov, and M S Sinyakov, and A Sh Norimov, and A V Nekrasov, and Podchernyaeva RYa, and I G Kharitonenkov, and M V Shchipanova
August 1997, The Journal of infectious diseases,
R V Petrov, and R M Khaitov, and V M Zhdanov, and M S Sinyakov, and A Sh Norimov, and A V Nekrasov, and Podchernyaeva RYa, and I G Kharitonenkov, and M V Shchipanova
January 1988, Doklady Akademii nauk SSSR,
R V Petrov, and R M Khaitov, and V M Zhdanov, and M S Sinyakov, and A Sh Norimov, and A V Nekrasov, and Podchernyaeva RYa, and I G Kharitonenkov, and M V Shchipanova
January 1988, Zeitschrift fur arztliche Fortbildung,
R V Petrov, and R M Khaitov, and V M Zhdanov, and M S Sinyakov, and A Sh Norimov, and A V Nekrasov, and Podchernyaeva RYa, and I G Kharitonenkov, and M V Shchipanova
February 1951, California medicine,
R V Petrov, and R M Khaitov, and V M Zhdanov, and M S Sinyakov, and A Sh Norimov, and A V Nekrasov, and Podchernyaeva RYa, and I G Kharitonenkov, and M V Shchipanova
April 1980, Schweizerische medizinische Wochenschrift,
R V Petrov, and R M Khaitov, and V M Zhdanov, and M S Sinyakov, and A Sh Norimov, and A V Nekrasov, and Podchernyaeva RYa, and I G Kharitonenkov, and M V Shchipanova
January 2015, Current topics in microbiology and immunology,
Copied contents to your clipboard!